The NHS has warned UK patients taking a commonly prescribed medication to seek urgent medical attention if they notice any of three specific symptoms. These can indicate serious complications due ...
Astrazeneca Korea Co. Ltd. will pull its blockbuster diabetes drug, Forxiga (dapagliflozin), from the South Korean market, a company official confirmed to BioWorld, citing “multiple factors” like ...
This medication is mainly used to treat type 2 diabetes but is also given to patients with heart failure and chronic kidney ...
Dapagliflozin is mainly prescribed for type 2 diabetes, but it is also used to treat heart failure and chronic kidney disease ...
AstraZeneca ($AZN) and Bristol-Myers Squibb ($BMY) look to be feeling good about the future of their diabetes drug Forxiga. The drugmakers have yanked the diabetes ...
Just days after winning groundbreaking coverage for a key cancer med, AstraZeneca ($AZN) on Friday notched another win from England’s cost-effectiveness watchdogs ...
FRANKFURT (Reuters) - AstraZeneca said combining its Forxiga type-2 diabetes drug with older medicine Bydureon was more effective at controlling blood sugar levels than treatment with either drug on ...
AstraZeneca and Bristol-Myers Squibb are celebrating following the approval of their diabetes drug Forxiga in the European Union. AstraZeneca and Bristol-Myers Squibb are celebrating following the ...
The EMA's approval of Forxiga for chronic kidney disease gives AstraZeneca access to millions of patients in the EU. Forxiga's efficacy and this massive potential market should help the label ...
A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble FRANKFURT (Reuters) - AstraZeneca said combining its Forxiga type-2 diabetes drug with older ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback